Before You Take Finasteride, Watch This

Key Wellness Strategies & Decision Framework (Finasteride / Hair-Loss Prevention)

Use targeted testing before starting therapy

• Marek Health uses a comprehensive hair-loss “panel” focused on the hormone systems driving androgenic alopecia—especially DHT/free androgen signaling—rather than generic labs.
• The goal is to determine both:
  • Likelihood of benefit/appropriateness (e.g., whether you’re likely to respond and how quickly you may progress)
  • Likelihood of side effects

Understand why DHT matters (and why side effects are possible)

• Androgenic alopecia in men is described as androgen-derived, with DHT treated as a primary driver.
• However, reducing DHT isn’t side-effect-free, so testing can help flag higher-risk patterns.

Assess hormone balance patterns that may predict side effects

The panel emphasizes measuring/estimating:

• Total vs. free DHT
• Androgen-to-estrogen ratio
• SHBG (sex hormone binding globulin)
• Propensity for male gynecomastia

It also considers potential impacts on mental/energy/motivation-related outcomes, including possible side effects such as:

• Lowered libido
• Erectile dysfunction
• Depression / reduced drive
• Gynecomastia

Consider baseline neurosteroid status

• The discussion includes whether finasteride could contribute to neurosteroid deficits.
• Since neurosteroids may be involved in calming/anxiety-reducing effects, checking baseline status is framed as potentially important.

Match treatment timing to developmental stage

• Earliest recommended time to seriously consider therapy: after full puberty.
• Rationale: starting earlier could theoretically interfere with maturation/masculinization (e.g., voice and penile size), so the approach is “why risk it?”

Weigh mental burden vs. medical risk (personal choice, not judgment)

• Hair loss can cause significant distress, and some people may not want to “just shave it” and instead want options that fit their mental health and preferences.
• The speaker emphasizes not imposing hair-loss coping strategies or medication choices on others.

Testing is “best practice,” but not mandatory

• If someone is budget constrained or wants to start quickly, the discussion acknowledges they may choose to begin without elaborate bloodwork.
• If someone is on the fence or strongly concerned about side effects, baseline testing is positioned as worthwhile for:
  • Getting a clearer “under the hood” picture
  • Feeling more comfortable with the decision

Presenter / Source List

• Derek (moreplatesmoredates.com) — co-founder perspective; host/lead
• Stephen Granzella — Director of Marketing, Marek Health
• Marek Health — company / hair-loss panel program (testing resource referenced)
• More Plates More Dates — YouTube channel mentioned as a related content source